AstraZeneca Pharma India Limited (ASTRAZEN) reports 30% revenue growth in Q1 FY2026-27, reaching INR 6,828 Mn, driven by strong portfolio and strategic partn.
AstraZeneca Pharma India Limited (ASTRAZEN) reports a consistent 33% growth in FY 2025-26, with total revenue reaching INR 22,755.8 Mn.